Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

EU antitrust regulators have asked pharma rivals and customers for feedback in four business areas in light of Novo Holdings' ...

Novo Nordisk announced that its board members and executives have sold a significant volume of shares, totaling 6,311,250 shares at a price of DKK 750.42 each, amounting to DKK 4.74 billion.

Novo Nordisk's (NVO) semaglutide, marketed as Wegovy for obesity, shows promise in reducing joint disease symptoms in ...

Novo Nordisk has successfully concluded a share repurchase program initiated on August 7, 2024, buying back B shares worth DKK 2.4 billion. This initiative is part of a larger plan to repurchase ...

Swiss biotech Alentis Therapeutics has secured $181.4 million, money that will be used to launch clinical trials for two ...

Novo Nordisk. "Novo Nordisk's sales increased by 24% in Danish kroner and by 25% at constant exchange rates to DKK 133.4 billion in the first six months of 2024." ...

If you’re looking for a reliable and high-performance ignition coil pack, the LCWRGS Set of 4 Ignition Coil Pack is a great option to consider. We recently tested the LCWRGS Set of 4 Ignition ...

As Novo Nordisk’s injectable diabetes-obesity duo Ozempic and Wegovy grab all the limelight, an oral version of the semaglutide drug showed it can provide heart-related benefits, too.

Novo Holdings is encountering more resistance as it aims to close its $16.5 billion acquisition of pharma manufacturing giant Catalent by the end of the year. A dozen consumer groups and trade ...

Novo Nordisk has asked the Food and Drug Administration to bar compounding pharmacies from making copies of its blockbuster weight loss drug semaglutide, arguing that the medication is too complex ...